Overcoming Challenges Facing Advanced Therapies in the EU Market
Sep 8, 2016
Authors: Mohamed Abou-El-Enein, Ahmed Elsanhoury, Petra Reinke.
Article in Cell Stem Cell, Volume 19, Issue 3, 1 September 2016, Pages 293–297. (doi: 10.1016/j.stem.2016.08.012)
While advanced therapy medicinal products offer great clinical promise, most EU-approved products have not achieved satisfactory commercial performance. Here we highlight a number of issues that prevent current products from obtaining commercial success and pitfalls that developers must overcome in future product development.